Supernus Pharmaceuticals Inc. said Monday that the
Food and Drug Administration approved its once-
per-day epilepsy drug Oxtellar XR. Its shares
jumped more than 10 percent in morning trading.
Please select the location that you were searching for from the list below.
Please try searching again using a valid zip code or city and state.
My Take, WaPo Columnist Clinton Yates: Commentary on life and pop culture
Copyright © 2014 by WTOP. All rights reserved.